] is required to make a threshold finding that a place of employment is unsafe-in the sense that significant risks are present and can be lessened by a change in practices" (448 U.S. at 642). The Occupational Safety and Health Administration (OSHA) has interpreted this to mean that whenever possible, it must quantify the risk associated with occupational exposure to a toxic substance at the current permissible exposure limit (PEL). If OSHA determines that there is significant risk to workers' health at its current standard, then it must quantify the risk associated with a variety of alternative standards to determine at what level, if any, occupational exposure to a substance no longer poses a significant risk.
For rulemaking on occupational exposure to 1,3-butadiene, there are two studies that are suitable for quantitative risk assessment. One is a mouse inhalation bioassay conducted by the National Toxicology Program (NTP), and the other is a rat inhalation bioassay conducted by Hazelton Laboratories Europe. Of the four risk assessments that have been submitted to OSHA, all four have used the mouse and/or rat data with a variety of models to quantify the risk associated with occupational exposure to 1,3-butadiene. In addition, OSHA has performed its own risk assessment using the female mouse and female rat data and the one-hit and multistage models. While these risk assessments differ'in the risks predicted at low doses, they all support OSHA's preliminary determination that there is significant risk of cancer from occupational exposure to 1,3-butadiene at the current OSHA PEL of 1000 ppm. OSHA plans to publish a proposal to revise the current 1,3-butadiene standard. In addition, OSHA will publish a request for public comment on the proposal. OSHA's final standard will be based on its evaluation of the public record and will be guided by significant risk determination. (3) . Adopted in 1971, this standard was aimed at preventing irritation and necrosis. Since that time, two animal bioassays have shown that 1,3-butadiene exposure induces cancer in rodents. The two studies, an inhalation bioassay conducted by the National Toxicology Program (NTP) using B6C3F1 mice (4) and an inhalation bioassay conducted by Hazelton Laboratories Europe (HLE) using CD rats of the SpragueDawley strain (5), demonstrated a dose-response relationship between exposure and carcinogenesis. In addition to this evidence of the carcinogenicity of 1,3-butadiene, four epidemiological studies have been conducted that show elevated death rates due to lymphohematopoietic cancers among workers exposed to 1,3-butadiene (6) (7) (8) (9) .
Following the Supreme Court's Benzene decision, OSHA must first determine whether workers face significant risk of cancer at exposures of 1000 ppm before it can consider reducing the current standard. In order to make this determination, OSHA reviews the public record and evaluates research and analyses on the occupational risk of 1,3-butadiene exposure. OSHA uses the research of others to develop its own preliminary assessment of risk. This assessment is published with a proposal for a revised standard. At that time, OSHA's assessment may be evaluated by scientists and interested parties outside of the Agency, and anyone may comment on the assessment.
For the rulemaking on 1,3-butadiene, five risk assessments have been submitted. Two of these are from the U.S. Environmental Protection Agency; one is from the Office of Toxic Substances (OTS) (10) , and the other is from the Carcinogenicity Assessment Group (CAG) (11) . A third risk assessment was performed under contract to OSHA by ICF/Clement Association (ICF) (12) , and a fourth was performed under contract to the Chemical Manufacturers Association by Environ Corporation (13 (14) . OSHA is currently reviewing this assessment which is a pharmocokinetic/mechanismbased analysis of the carcinogenic risk of 1,3-butadiene.
All of these risk assessments relied on the animal bioassay data for quantifying carcinogenic risk. While there is less uncertainty in extrapolating risks from human data, none of the available epidemiological studies provide adequate exposure data for such an assessment. Therefore, risk assessments must rely upon the animal data for their analyses. Both bioassays have the advantage that the route of exposure is the same as the one found in occupational settings (i.e., inhalation), the animals were exposed to at least two different levels of the test substance, and concurrent controls were used. In addition, data on the absorption of 1,3-butadiene in both mice and rats are available and can be used to estimate internal dose (15) .
Extrapolating risks from animals to humans entails five steps before risks may be estimated. Choices made by a risk assessor at each of these steps will affect the outcome of a risk assessment, and therefore OSHA's evaluation of a quantitative risk assessment centers on these choices. All of the risk assessments submitted to OSHA differ in the choices made.
The first step in performing a quantitative risk assessment entails choosing a data set for low-dose extrapolation. OTS and ICF considered only the male and female mice; CAG used the males and females of both species; and Eviron used the male and female rats but only the male mice.
Although exposure levels are determined in the design of a bioassay, the risk (17) . Following CAG, OSHA calculated the geometric mean of the MLEs derived individually from the male mouse data and the female mouse data. The same was done for the UCLs. CAG reasoned that because response was so similar between male and female mice, the geometric mean of the risks was an appropriate estimate. While CAG adjusted its estimate of unit risk for early termination of the NTP study, the numbers in Table 1 were not adjusted. OSHA has preliminarily stated that occupational exposure to 1,3-butadiene poses a significant risk. In addition to demonstrating a health need for a standard, however, OSHA's standards must be economically and technologically feasible; to that end, it has contracted for an economic and engineering survey of the industries affected by the standard. Given preliminary reports of feasibility, OSHA is proceeding with the publication of a proposal for a revised standard. Following publication, there will be a comment period and then informal hearings will be held. OSHA's final standard will be based upon its evaluation of the public record and will be guided by the Supreme Court's Benzene decision on significant risk determination.
